Lipid‐Facilitated Opening of the ADAM10 Sheddase Revealed by Enhanced Sampling Simulations
ADAM10 is a crucial membrane-bound metalloprotease that regulates cellular physiology by cleaving and releasing membrane-anchored proteins, including adhesion molecules and growth factor precursors, thereby modulating cell signaling, adhesion, and migration. Despite its central role, its activation mechanisms are not fully understood. Here, we model how phosphatidylserine (PS) exposure during apoptosis triggers ADAM10 activation. We confirm that PS externalization is associated with ADAM10-mediated CD43 shedding from the surface of T cells. Intriguingly, ADAM10 activation correlated with loss of ADAM10 monoclonal antibody binding, suggesting a PS-induced conformational change that alters epitope accessibility. To explore this lipid-mediated conformational change of ADAM10, we employed molecular dynamics simulations to map its conformational landscape. Our simulations revealed that in the absence of PS, ADAM10 samples predominantly closed and intermediate states. By contrast, the presence of PS destabilizes the closed conformation, thereby favoring open states. We provide a mechanistic explanation for this PS-induced conformational change, which drives ADAM10 activation and loss of mAb binding through conformational change. These findings offer new insights into the lipid-mediated regulation of ADAM10 and its conformational dynamics.
Authors
- Lucie Delemotte (ORCID: https://orcid.org/0000-0002-0828-3899)
- Shengpan Zhang (ORCID: https://orcid.org/0000-0002-1134-7101)
- Nandan Haloi (ORCID: https://orcid.org/0000-0003-3542-333X)
- Adrien Schahl (ORCID: https://orcid.org/0000-0001-5839-7715)
- Marta Carroni (ORCID: https://orcid.org/0000-0002-7697-6427)
- Erdinc Sezgin
- Quentin James Sattentau
Institutions
- Max Delbrück Center (DE)
- Science for Life Laboratory (SE)
- Karolinska Institutet (SE)
- University of Oxford (GB)
- CRUK/MRC Oxford Institute for Radiation Oncology (GB)
- KTH Royal Institute of Technology (SE)
Publication Details
- Journal
- Advanced Science
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1002/advs.202515713
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- UK Research and Innovation
- University of Oxford
- Karolinska Institutet
- Knut och Alice Wallenbergs Stiftelse
- Vetenskapsrådet
- China Scholarship Council
- Science for Life Laboratory
- Medical Research Council